Founder-led precision immunology company

Reprogramming autoimmune disease through cellular precision

Selective elimination of pathogenic immune cell subsets to enable durable immune reset.

Built on human genetics, immune biology, and translational insight.

Beyond cytokine blockade

Targeting the cellular drivers of disease rather than downstream inflammatory mediators.

Advancing precision antibody therapeutics

Selective elimination of pathogenic immune subsets while avoiding broad immunosuppression.

Selective depletion. Functional reset.

Durable control of autoimmune disease requires cellular precision.